SIRNA COMPOUNDS COMPRISING TERMINAL SUBSTITUTIONS

The invention relates to modified siRNA compounds which down-regulate target gene expression, to pharmaceutical compositions comprising such compounds and to methods of treating and/or preventing the incidence or severity of various diseases or conditions associated with the genes and/or symptoms as...

Full description

Saved in:
Bibliographic Details
Main Author AVKIN-NACHUM SHARON
Format Patent
LanguageEnglish
Published 04.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to modified siRNA compounds which down-regulate target gene expression, to pharmaceutical compositions comprising such compounds and to methods of treating and/or preventing the incidence or severity of various diseases or conditions associated with the genes and/or symptoms associated with such diseases or conditions.
AbstractList The invention relates to modified siRNA compounds which down-regulate target gene expression, to pharmaceutical compositions comprising such compounds and to methods of treating and/or preventing the incidence or severity of various diseases or conditions associated with the genes and/or symptoms associated with such diseases or conditions.
Author AVKIN-NACHUM SHARON
Author_xml – fullname: AVKIN-NACHUM SHARON
BookMark eNrjYmDJy89L5WQwDPYM8nNUcPb3DfAP9XMJBrOCPIM9_dwVQlyDfD39HH0UgkOdgkM8Q0JDPP39gnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoamhqZGJoZGjoTFxqgA0jynU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2015152412A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2015152412A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:56:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2015152412A13
Notes Application Number: US201414451233
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150604&DB=EPODOC&CC=US&NR=2015152412A1
ParticipantIDs epo_espacenet_US2015152412A1
PublicationCentury 2000
PublicationDate 20150604
PublicationDateYYYYMMDD 2015-06-04
PublicationDate_xml – month: 06
  year: 2015
  text: 20150604
  day: 04
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies AVKIN-NACHUM SHARON
QUARK PHARMACEUTICALS, INC
RelatedCompanies_xml – name: AVKIN-NACHUM SHARON
– name: QUARK PHARMACEUTICALS, INC
Score 2.9825354
Snippet The invention relates to modified siRNA compounds which down-regulate target gene expression, to pharmaceutical compositions comprising such compounds and to...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title SIRNA COMPOUNDS COMPRISING TERMINAL SUBSTITUTIONS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150604&DB=EPODOC&locale=&CC=US&NR=2015152412A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFfWmVbFaZUHZ22K3m-zjUKT7qF2x2dJspLfS7AME2Ra74t83ia321FuSgckDJvPINxOAh94CLVzb6RpO3uUGEkrEcEsby2iT5bk8l2g2ibYg9oihlxmeNeBjmwuj6oR-q-KIQqIyIe-1uq9X_0GsUGEr14_8XQwtn4ZpP9Q33vFvuTw99PvRJAmTQA-CPqM6mSqaUFXI7A2Er3QgDGlHAsCiN1_mpax2lcrwFA4ngl9Vn0GjqFpwHGz_XmvB0Xjz5C2aG-lbn4NJ4ykZaEEyniSMhFS1pjGNybMmrNJxTAavGmU-TeOUqfTgC7gfRmkwMsTc87-tzhndXah1Cc1qWRVXoHnIXPR4mWPL5kjKTckd03PLLCswzizchs4-Ttf7yTdwIrsKAoU60Kw_v4pboWxrfqfO6AfYInzU
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokYUdYlmb4uMtWM8EMM2kOnWLXQzvBE6tsTEDCIz_vu2dShPvF16yfUjud5Hf3cFeOgu0MIyex2tt-wwDXEjolm5iUW2yehbbCnQbAJtQcxJgl5meFaDj20tjOwT-i2bI3KNSrm-l_K-Xv8nsVyJrdw8snc-tHoaxwNXraLj33Z5qmsPRlHoho7qOIOEqmQqedxUIb075LHSAXeyLdFpf_Rmi7qU9a5RGZ_AYcTlFeUp1LKiCQ1n-_daE46C6smbk5X2bc5Ap96UDBUnDKIwIS6V1NSjHnlWuFcaeGToKzSxaezFiSwPPof78Sh2Jhqfe_631XlCdxdqXEC9WBXZJSh9pC-6LF9iw2RI6E3OenrfytM0wzg1cAva-yRd7WffQWMSB_7c98jrNRwLloRDoTbUy8-v7IYb3pLdyvP6AdqCf8Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SIRNA+COMPOUNDS+COMPRISING+TERMINAL+SUBSTITUTIONS&rft.inventor=AVKIN-NACHUM+SHARON&rft.date=2015-06-04&rft.externalDBID=A1&rft.externalDocID=US2015152412A1